Centaur Pharmaceuticals Private Limited

FDA inspection history in Pune, India, 2023

1
Warning letter
1
Form 483

Every document, by year

  • Warning letter
  • Form 483

2023: one warning letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2023One warning letter and one Form 483, at Pune, India.

Cited most

Across all Centaur Pharmaceuticals Private Limited observations on file

The complete Centaur Pharmaceuticals Private Limited file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2023-07-25Warning letter Warning letter$99
2023-02-08483 Form 483$99

Investigators on these documents

Pratik S. Upadhyay (1)

FEI number 3008861619 · most recent document Jul 25, 2023

About Centaur Pharmaceuticals Private Limited

How many FDA Form 483s has Centaur Pharmaceuticals Private Limited received?

FDA Intel has 1 Form 483 on file for Centaur Pharmaceuticals Private Limited; the most recent is dated Feb 8, 2023.

When was Centaur Pharmaceuticals Private Limited last inspected by FDA?

The most recent FDA inspection document on file for Centaur Pharmaceuticals Private Limited is a Form 483 dated Feb 8, 2023, for the site in Pune, India.

What did FDA cite at Centaur Pharmaceuticals Private Limited?

The regulations cited most in the observations on file for Centaur Pharmaceuticals Private Limited are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.63 (Equipment design, size, and location), 1 time.

Has Centaur Pharmaceuticals Private Limited received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Centaur Pharmaceuticals Private Limited; the most recent is dated Jul 25, 2023.